Menrva - AI Enhanced Menopause Care

Background

Overview

Menrva is a health intelligence and telemedicine platform dedicated to providing personalized, proactive, and predictive data-driven care for women navigating perimenopause, menopause, and post-menopause stages. The company aims to address the root causes of hormonal and metabolic shifts through advanced digital intelligence and functional medicine.

Mission and Vision

Menrva's mission is to empower women through precision, personalization, and proactive care in menopause management, utilizing cutting-edge applications, analytics, and telemedicine services to deliver support from the comfort of home or office. The vision is to reimagine menopause as a phase of growth and well-being, setting new standards for opportunities for women worldwide.

Industry Significance

The global menopause care market is projected to reach $24.35 billion by 2030, driven by over one billion women entering menopause by 2025. Menrva's innovative approach positions it to capture a significant share of this expanding market, addressing the critical need for personalized and accessible menopause care.

Key Strategic Focus

Core Objectives

Personalized Care: Develop individualized health profiles and treatment plans based on comprehensive lab testing and monitoring.

Telemedicine Expansion: Provide telemedicine services across all 50 states, ensuring broad accessibility.

Technological Integration: Utilize AI-driven tools and mobile applications to enhance patient engagement and care delivery.

Areas of Specialization

Hormonal Health: Focus on balancing hormones through bioidentical hormone replacement therapy (BHRT).

Functional Medicine: Address root causes of health issues using a holistic, patient-centered approach.

Symptom Management: Offer solutions for common menopause symptoms such as hot flashes, night sweats, and mood swings.

Key Technologies Utilized

AI Clinical Assistant and Care Coach: Provide continuous monitoring, personalized guidance, and real-time support for patients.

Mobile Application: An all-in-one interface for symptom tracking, AI-driven health plans, and access to personalized HRT treatment.

Telemedicine Platform: Connects patients with hormone specialist clinicians and nutritionists for personalized care and prescription management.

Primary Markets Targeted

Geographic Reach: Services available in all 50 states and U.S. territories.

Demographic Focus: Women experiencing perimenopause, menopause, and post-menopause.

Financials and Funding

Funding History

Menrva is currently raising a $1.5 million seed round to achieve product-market fit, expand its user base, and further develop its technology platform. The company has a proven foundation with an existing clinic generating $1.8 million in annual revenue, an 89.7% two-year retention rate, and a growing base of telemedicine clients.

Utilization of Capital

Product Development: Enhance and expand the mobile application and telemedicine platform.

Market Expansion: Increase marketing efforts to attract a broader user base.

Operational Scaling: Support the integration of additional healthcare professionals and resources.

Pipeline Development

Key Pipeline Candidates

Mobile Application: Scheduled for launch in Q1 2026, offering proactive, personalized tracking and information for women.

Telemedicine Services: Expanded Menopause Method BHRT telemedicine services launched in Q1 2025, available in all 50 states.

Target Conditions

Hormonal Imbalance: Addressing symptoms related to perimenopause, menopause, and post-menopause.

Metabolic Shifts: Managing changes in metabolism associated with hormonal transitions.

Anticipated Milestones

Q1 2026: Launch of the Menrva mobile application.

Ongoing: Expansion of telemedicine services and user base.

Technological Platform and Innovation

Proprietary Technologies

AI Clinical Assistant and Care Coach: Provides continuous monitoring and personalized guidance.

Mobile Application: An integrated platform for symptom tracking, health plans, and HRT access.

Significant Scientific Methods

Functional Medicine Approach: Utilizes comprehensive lab testing and personalized treatment plans.

AI-Driven Health Plans: Offers tailored health plans based on individual data and symptoms.

Leadership Team

Dr. Betty Murray – Founder & CEO

A nationally recognized leader in functional medicine and women's health, Dr. Murray has over 20 years of clinical experience. She is the visionary behind The Menrva Project and hosts the "Menopause Mastery" podcast.

Kelly Resendez – President & COO

A transformational business strategist, Resendez previously served as Executive Vice President of Talent and Growth at GoodLeap. She is a nationally recognized thought leader bridging technology, healthcare, and personal development.

Geoff Scott – Chief Technology Officer

Oversees the technological development and integration of Menrva's platforms, ensuring seamless user experiences and innovative solutions.

Kari Thortensen – VP Product Development

Leads the product development team, focusing on creating and enhancing Menrva's offerings to meet user needs effectively.

Competitor Profile

Market Insights and Dynamics

The global menopause care market is projected to reach $24.35 billion by 2030, driven by over one billion women entering menopause by 2025. This growth is fueled by increasing awareness and demand for personalized, accessible menopause care solutions.

Competitor Analysis

Hims & Hers Health: Expanding into women's health with AI-powered telehealth and personalized hormone therapies, aiming for $1 billion in revenue by 2026.

Naviday Health: Developing AI-guided menopause care plans through the Mayo Clinic Platform_Accelerate program, focusing on personalized, real-time support.

MenoLabs: Offers natural menopause symptom relief supplements and has been acquired by Amyris, indicating strong market interest.

Strategic Collaborations and Partnerships

Menrva's partnership with the Mayo Clinic Platform_Accelerate program enhances its technological capabilities and credibility in the healthcare sector.

Operational Insights

Menrva's integration of AI-driven tools and telemedicine services provides a scalable and accessible model, differentiating it from competitors by offering personalized, data-driven care without geographic limitations.

Strategic Opportunities and Future Directions

Strategic Roadmap

Product Expansion: Launch the Menrva mobile application in Q1 2026 to enhance user engagement and care personalization.

Market Penetration: Leverage telemedicine services to reach underserved populations and expand the user base.

Technological Innovation: Continue to integrate advanced AI and data analytics to refine care plans and improve outcomes.

Future Business Directions

Menrva aims to become a leading provider of personalized menopause care, setting new standards for women's health through innovative technology and comprehensive support.